DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Pfützner A, Hanefeld M, Lübben G, Weber MM, Karagiannis E, Köhler C, Hohberg C, Forst T.
Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk – results from the PIOSTAT study.
Horm Metab Res 2007; 39: 764-768
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.